Biotechnology and Pharmaceutical Law Review

In the fall of 2006, North Carolina Central University School of Law created the first Biotechnology and Pharmaceutical Law Institute. The mission of the Institute is to make substantial contributions to the development of biotechnology and pharmaceutical law. The Institute focuses on: biotechnology, bioethics, pharmaceutical regulation, and technology transfer.

From the Institute, the Biotechnology and Pharmaceutical Law Review (BPLR), formally known as the Journal of Biotechnology and Pharmaceutical Law, emerged. As one of the only legal reviews of its kind in the nation and the newest law review at NCCU School of Law, the Biotechnology and Pharmaceutical Law Review occupies a unique place within the law school community. Its goal is to expose and transform these research areas through scholarly work that analyzes and critiques newly developed issues in this realm. The Biotechnology and Pharmaceutical Law Review seeks to publish a professional periodical devoted to these areas that are useful to judges, practitioners, teachers, legislators, students and others interested in these practice areas.

In the spring of 2008, the Biotechnology and Pharmaceutical Law Review successfully published its first issue and remains an annual publication. Generally, an issue consists of a collection of articles, notes, comments, and hot topics. Additionally, once a year, the Biotechnology and Pharmaceutical Law Review hosts a successful symposium devoted to a single legal problem or issue in the related research areas.